These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2307935)

  • 1. Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.
    Baumgartner JD; Heumann D; Gerain J; Weinbreck P; Grau GE; Glauser MP
    J Exp Med; 1990 Mar; 171(3):889-96. PubMed ID: 2307935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G; Heumann D; Gérain J; Kohler J; Abbet P; Barras C; Lucas R; Glauser MP; Baumgartner JD
    J Immunol; 1992 Mar; 148(6):1890-7. PubMed ID: 1541827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunoprotective monoclonal antibody to lipopolysaccharide.
    Kirkland TN; Ziegler EJ
    J Immunol; 1984 May; 132(5):2590-2. PubMed ID: 6201551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction.
    Ozmen L; Pericin M; Hakimi J; Chizzonite RA; Wysocka M; Trinchieri G; Gately M; Garotta G
    J Exp Med; 1994 Sep; 180(3):907-15. PubMed ID: 7914909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
    Mashimo J; Mizutani T; Mita A; Kasai N
    Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of production of tumor necrosis factor by monoclonal antibodies to lipopolysaccharides.
    Vacheron F; Mandine E; Lenaour R; Smets P; Zalisz R; Guenounou M
    J Infect Dis; 1992 May; 165(5):873-8. PubMed ID: 1569336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation of LPS ability to induce the local Shwartzman reaction.
    Aguillón JC; Ferreira V; Núñez E; Paredes L; Molina MC; Colombo A; Hermosilla T; Ferreira A
    Scand J Immunol; 1996 Dec; 44(6):551-5. PubMed ID: 8972735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
    J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A.
    Cornelissen JJ; Mäkel I; Algra A; Benaissa-Trouw BJ; Schellekens JF; Kraaijeveld CA; Verhoef J
    J Infect Dis; 1993 Apr; 167(4):876-81. PubMed ID: 8450253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of meningococcal endotoxin by antibody to core glycolipid.
    Davis CE; Ziegler EJ; Arnold KF
    J Exp Med; 1978 Apr; 147(4):1007-17. PubMed ID: 418134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages.
    Chia JK; Pollack M; Guelde G; Koles NL; Miller M; Evans ME
    J Infect Dis; 1989 May; 159(5):872-80. PubMed ID: 2651532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serological specificity of anti-endotoxin sera directed against whole bacterial cells and core oligosaccharide of Escherichia coli J5-tetanus toxoid conjugate.
    Lukasiewicz J; Jachymek W; Niedziela T; Malik-Gebicka M; Dzieciatkowska M; Lugowski C
    Acta Biochim Pol; 2002; 49(3):721-34. PubMed ID: 12422242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against core and O antigen epitopes of Escherichia coli O83 in rabbit antisera and in commercial human immunoglobulin.
    Orskov F; Orskov I
    Med Microbiol Immunol; 1991; 180(3):157-66. PubMed ID: 1717815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of the active fraction from the tuber of Scirpus yagara in mouse endotoxin shock model.
    Li P; Liang QL; Cui XD; Li J; Zou NS; Wu QN; Duan JA
    J Ethnopharmacol; 2014 Dec; 158 Pt A():331-7. PubMed ID: 25446641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective anti-lipopolysaccharide monoclonal antibodies inhibit tumor necrosis factor production.
    Cody CS; Burd RS; Mayoral JL; Dunn DL
    J Surg Res; 1992 Apr; 52(4):314-9. PubMed ID: 1593869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
    Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM
    J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration in vivo of recombinant interleukin 2 protects mice against septic death.
    Weyand C; Goronzy J; Fathman CG; O'Hanley P
    J Clin Invest; 1987 Jun; 79(6):1756-63. PubMed ID: 3294901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
    J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.